NCT00157703View on ClinicalTrials.gov

G207 Followed by Radiation Therapy in Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

October 31, 2008

Study Completion Date

December 31, 2008

Conditions
Malignant Glioma
Interventions
DRUG

G207

1 x 10E9 plaque forming units, administered by stereotactic injections into the tumor (single administration)

Trial Locations (1)

35294-3410

University of Alabama at Birmingham, Birmingham

Sponsors

Lead Sponsor

MediGene
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

MediGene

INDUSTRY